Stammdaten
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
Unternehmen & Branche
| Name | BullFrog AI Holdings, Inc. |
|---|---|
| Ticker | BFRG |
| CIK | 0001829247 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 7,1 Mio. USD |
| Beta | -2,30 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 116,670 | -6,498,068 | -0.63 | 2,808,351 | 2,136,329 |
| 2025-09-30 | 10-Q | 83,413 | -1,551,612 | -0.15 | 2,702,356 | 1,943,655 |
| 2025-06-30 | 10-Q | 33,257 | -1,448,729 | -0.15 | 2,869,194 | 2,188,110 |
| 2025-03-31 | 10-Q | -2,017,553 | -0.21 | 4,085,872 | 3,246,475 | |
| 2024-12-31 | 10-K | -6,993,647 | -0.85 | 5,551,830 | 4,963,740 | |
| 2024-09-30 | 10-Q | -1,763,464 | -0.22 | 4,602,206 | 3,823,169 | |
| 2024-06-30 | 10-Q | -1,611,646 | -0.20 | 6,076,555 | 5,385,062 | |
| 2024-03-31 | 10-Q | -1,903,794 | -0.26 | 7,648,856 | 6,804,326 | |
| 2023-12-31 | 10-K | 65,000 | -5,355,869 | -0.89 | 2,776,586 | 2,592,236 |
| 2023-09-30 | 10-Q | 65,000 | -1,252,978 | -0.21 | 4,214,876 | 3,768,826 |
| 2023-06-30 | 10-Q | -1,480,398 | -0.24 | 6,042,012 | 4,900,344 | |
| 2023-03-31 | 10-Q | -1,325,547 | -0.27 | 6,233,087 | 4,623,817 | |
| 2022-12-31 | 10-K | 10,000 | -2,802,487 | -0.70 | 80,369 | -3,057,352 |
| 2022-09-30 | 10-Q | -764,693 | -0.16 | -2,413,360 | ||
| 2022-06-30 | 10-Q | -775,917 | -0.17 | -1,892,281 | ||
| 2022-03-31 | 10-Q | -566,359 | -1,554,186 | |||
| 2021-12-31 | 10-K | -585,840 | 10,014 | -1,009,107 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.